Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

cronos

  • Home
  •  
  • cronos



  • Most Read
  • Latest Comments
  • Vitura Health brand overhaul spells success story with successful results
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Vitura Health brand overhaul spells success story with successful results
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Vitura Health brand overhaul spells success story with successful results
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Vitura Health brand overhaul spells success story with successful results
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Vitura Health brand overhaul spells success story with successful results
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Vitura’s Cortexa becomes first Aus company to supply ecstasy and magic mushrooms under TGA’s prescriber scheme
    Vitura’s Cortexa becomes first Aus company to supply ecstasy and magic mushrooms under TGA’s prescriber scheme
    • News

  • Vape imports banned, Vitura introduces nicotine vaping products to tap new market
    Vape imports banned, Vitura introduces nicotine vaping products to tap new market
    • News

  • Vitura receives first MDMA for its newly-minted psychedelics arm Cortexa
    Vitura receives first MDMA for its newly-minted psychedelics arm Cortexa
    • News

  • From cannabis to telehealth, Vitura expands portfolio with $25m Doctors on Demand acquisition
    From cannabis to telehealth, Vitura expands portfolio with $25m Doctors on Demand acquisition
    • News

  • Vitura declares dividend for the second time amid growing cannabis profits
    Vitura declares dividend for the second time amid growing cannabis profits
    • News

  • Vitura Health brand overhaul spells success story with successful results
    • News

    Vitura Health brand overhaul spells success story with successful results

    Leading cannabis company providing a safe and reliable source of cannabis treatment products, Vitura Health (ASX: VIT) has released its financial results for the first half of FY2023, revealing a significant step up across the board following their recent business overhaul finalised earlier this year. You may not recognise the Company or its name just

    Read More
    Public
  • Cronos all set to launch new version of app to sell cannabis
    • News

    Cronos all set to launch new version of app to sell cannabis

    Cannabis consumers rejoice, medicinal cannabis provider Cronos Australia (ASX:CAU) is very close to finally releasing its Canview platform to make the procurement of the drug an easy affair. The roll-out is happening across stages with the first one comprising a number of order fulfilment upgrades, process improvements and other efficiencies. It was deployed internally within

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.